Breaking News

Ofichem Group to Acquire Avivia

Strengthens Ofichem’s integrated development offering, enabling it to offer broader, deeper support from early-phase development through to GMP production.

Author Image

By: Charlie Sternberg

Associate Editor

Ofichem Group has agreed to acquire Avivia B.V., a company specialized in formulation development based in Nijmegen, the Netherlands. The acquisition marks a significant step in Ofichem’s strategy to become a fully integrated provider of development solutions across drug substance and drug product, with a focus on complex formulations. Avivia is a Contract Development Organization (CDO) with expertise in formulation development, analytical method development, dissolution testing, and excipien...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters